Loading...

Morphic Holding, Inc.

MORFNASDAQ
Healthcare
Biotechnology
$56.99
$0.02(0.04%)
U.S. Market opens in 61h 19m

Morphic Holding, Inc. Fundamental Analysis

Morphic Holding, Inc. (MORF) shows weak financial fundamentals with a PE ratio of -15.88, profit margin of -291.93%, and ROE of -29.08%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position29.16%
Current Ratio28.94

Areas of Concern

ROE-29.08%
Operating Margin-342.97%
We analyze MORF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -27372.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-27372.3/100

We analyze MORF's fundamental strength across five key dimensions:

Efficiency Score

Weak

MORF struggles to generate sufficient returns from assets.

ROA > 10%
-21.05%

Valuation Score

Excellent

MORF trades at attractive valuation levels.

PE < 25
-15.88
PEG Ratio < 2
1.41

Growth Score

Weak

MORF faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

MORF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
28.94

Profitability Score

Weak

MORF struggles to sustain strong margins.

ROE > 15%
-2907.73%
Net Margin ≥ 15%
-291.93%
Positive Free Cash Flow
No

Key Financial Metrics

Is MORF Expensive or Cheap?

P/E Ratio

MORF trades at -15.88 times earnings. This suggests potential undervaluation.

-15.88

PEG Ratio

When adjusting for growth, MORF's PEG of 1.41 indicates fair valuation.

1.41

Price to Book

The market values Morphic Holding, Inc. at 3.47 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.47

EV/EBITDA

Enterprise value stands at -16.43 times EBITDA. This is generally considered low.

-16.43

How Well Does MORF Make Money?

Net Profit Margin

For every $100 in sales, Morphic Holding, Inc. keeps $-291.93 as profit after all expenses.

-291.93%

Operating Margin

Core operations generate -342.97 in profit for every $100 in revenue, before interest and taxes.

-342.97%

ROE

Management delivers $-29.08 in profit for every $100 of shareholder equity.

-29.08%

ROA

Morphic Holding, Inc. generates $-21.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-21.05%

Following the Money - Real Cash Generation

Operating Cash Flow

Morphic Holding, Inc. generates limited operating cash flow of $-133.07M, signaling weaker underlying cash strength.

$-133.07M

Free Cash Flow

Morphic Holding, Inc. generates weak or negative free cash flow of $-134.54M, restricting financial flexibility.

$-134.54M

FCF Per Share

Each share generates $-2.68 in free cash annually.

$-2.68

FCF Yield

MORF converts -3.97% of its market value into free cash.

-3.97%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.88

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

1.41

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.47

vs 25 benchmark

P/S Ratio

Price to sales ratio

5493.87

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.003

vs 25 benchmark

Current Ratio

Current assets to current liabilities

28.94

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.29

vs 25 benchmark

ROA

Return on assets percentage

-0.21

vs 25 benchmark

ROCE

Return on capital employed

-0.26

vs 25 benchmark

How MORF Stacks Against Its Sector Peers

MetricMORF ValueSector AveragePerformance
P/E Ratio-15.8828.81 Better (Cheaper)
ROE-29.08%643.00% Weak
Net Margin-29192.90%-44312.00% (disorted) Weak
Debt/Equity0.000.36 Strong (Low Leverage)
Current Ratio28.944.50 Strong Liquidity
ROA-21.05%-17799.00% (disorted) Weak

MORF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Morphic Holding, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ